464 related articles for article (PubMed ID: 32124117)
1. Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review.
Solar P; Mackerle Z; Joukal M; Jancalek R
Neurosurg Rev; 2021 Apr; 44(2):649-658. PubMed ID: 32124117
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
[TBL] [Abstract][Full Text] [Related]
3. Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial.
Lin F; Li R; Chen Y; Yang J; Wang K; Jia Y; Han H; Hao Q; Shi G; Wang S; Zhao Y; Chen X
Trials; 2024 Jun; 25(1):377. PubMed ID: 38863026
[TBL] [Abstract][Full Text] [Related]
4. Investigational drugs for vasospasm after subarachnoid hemorrhage.
Tallarico RT; Pizzi MA; Freeman WD
Expert Opin Investig Drugs; 2018 Apr; 27(4):313-324. PubMed ID: 29600883
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Prevention of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.
Caylor MM; Macdonald RL
Neurocrit Care; 2024 Feb; 40(1):159-169. PubMed ID: 37740138
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
[TBL] [Abstract][Full Text] [Related]
7. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
Vergouwen MD; de Haan RJ; Vermeulen M; Roos YB
Stroke; 2010 Jan; 41(1):e47-52. PubMed ID: 19875741
[TBL] [Abstract][Full Text] [Related]
8. Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Ditz C; Matone MV; Schwachenwald B; Küchler J
Neurosurg Rev; 2024 Jan; 47(1):37. PubMed ID: 38191859
[TBL] [Abstract][Full Text] [Related]
9. Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Akbik F; Waddel H; Jaja BNR; Macdonald RL; Moore R; Samuels OB; Sadan O
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106020. PubMed ID: 34365121
[TBL] [Abstract][Full Text] [Related]
10. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
[TBL] [Abstract][Full Text] [Related]
11. An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.
Maruhashi T; Higashi Y
Expert Opin Pharmacother; 2021 Aug; 22(12):1601-1614. PubMed ID: 33823726
[No Abstract] [Full Text] [Related]
12. Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial.
Naraoka M; Matsuda N; Shimamura N; Asano K; Akasaka K; Takemura A; Hasegawa S; Ohkuma H
J Cereb Blood Flow Metab; 2018 Jul; 38(7):1190-1198. PubMed ID: 28762878
[TBL] [Abstract][Full Text] [Related]
13. Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience.
Ditz C; Machner B; Schacht H; Neumann A; Schramm P; Tronnier VM; Küchler J
Neurosurg Rev; 2021 Oct; 44(5):2899-2912. PubMed ID: 33492514
[TBL] [Abstract][Full Text] [Related]
14. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
[TBL] [Abstract][Full Text] [Related]
15. Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study.
Muraoka S; Asai T; Fukui T; Ota S; Shimato S; Koketsu N; Nishizawa T; Araki Y; Saito R
Neurosurg Rev; 2023 Aug; 46(1):195. PubMed ID: 37555872
[TBL] [Abstract][Full Text] [Related]
16. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
Smetana KS; Buschur PL; Owusu-Guha J; May CC
Crit Care Nurs Q; 2020; 43(2):138-156. PubMed ID: 32084059
[TBL] [Abstract][Full Text] [Related]
18. Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Beyond Vasospasm and Towards a Multifactorial Pathophysiology.
Geraghty JR; Testai FD
Curr Atheroscler Rep; 2017 Oct; 19(12):50. PubMed ID: 29063300
[TBL] [Abstract][Full Text] [Related]
19. Effects of Various Therapeutic Agents on Vasospasm and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage-Results of a Network Meta-Analysis.
Mishra S; Garg K; Gaonkar VB; Singh PM; Singh M; Suri A; Chandra PS; Kale SS
World Neurosurg; 2021 Nov; 155():41-53. PubMed ID: 34339892
[TBL] [Abstract][Full Text] [Related]
20. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T
J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
